ArticleNature communications2026
Hydrogen sulfide engages catalytic zinc in HDAC6 to modulate an alternative deacetylation pathway.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
Abstract
Hydrogen sulfide (H₂S) is a gasotransmitter whose non-covalent effects on protein function remain incompletely understood. Here we show that H₂S-derived sulfur species engage the catalytic Zn²⁺ center of histone deacetylase 6 (HDAC6) and enhance deacetylase activity under defined conditions. Molecular dynamics simulations support access of HS⁻ to the CD2 active-site tunnel, whereas surface plasmon resonance and zinc-depletion experiments support reversible, zinc-dependent engagement. Quantum chemical calculations support a chemically feasible sulfur-associated deacetylation pathway that generates thioacetic acid, which we detect in cell-free reactions, cultured cells, mouse tissues and human serum. Cryo-electron microscopy defines the tandem organization of human HDAC6 catalytic domains and reveals distinct CD1 and CD2 tunnel architectures. HDAC6 loss blunts H₂S-induced endothelial migration and angiogenesis, and CD2 is required for these responses. These findings support HDAC6 as an H₂S-responsive Zn²⁺-dependent deacetylase and link zinc-sulfur coordination to altered deacetylation chemistry.
Indexed as
Identifiers
42918798What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.